TMOD1 and hepatocellular carcinoma: Afterwards, in vitro and in vivo experiments showed that overexpression of TMOD1 reversed the inhibitory effects of miR-MTCO3P38 on migration and invasion of HCC cells and tumor growth, illustrating that miR-MTCO3P38 restrained tumor growth and development by targeting TMOD1/MMP13 pathway.